<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5091">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04302766</url>
  </required_header>
  <id_info>
    <org_study_id>S-20-01</org_study_id>
    <nct_id>NCT04302766</nct_id>
  </id_info>
  <brief_title>Expanded Access Remdesivir (RDV; GS-5734™)</brief_title>
  <official_title>Intermediate-Size Patient Population Expanded Access Treatment Protocol for Coronavirus Disease 2019 (COVID-19) Remdesivir (RDV; GS-5734™)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>U.S. Army Medical Research and Development Command</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>U.S. Army Medical Research and Development Command</source>
  <brief_summary>
    <textblock>
      Disease caused by 2019 Novel Coronavirus also known as severe acute respiratory syndrome&#xD;
      coronavirus 2 (SARS-CoV-2)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment of communicable Novel Coronavirus (CODIV-19) of 2019 with Remdesivir (RDV;&#xD;
      GS-5734™) also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>No longer available</overall_status>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <expanded_access_info>
    <expanded_access_type_intermediate>Yes</expanded_access_type_intermediate>
    <expanded_access_type_treatment>Yes</expanded_access_type_treatment>
  </expanded_access_info>
  <condition>Coronavirus Disease 2019</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remdesivir</intervention_name>
    <description>Remdesivir (RDV,GS-5734) is a monophosphoramidate prodrug of an adenosine analog with potent activity against an array of RNA virus families including Filoviridae, Paramyxoviridae, Pneumoviridae, and Orthocoronavirinae, through the targeting of the viral RNA dependent RNA polymerase (RdRp).</description>
    <other_name>GS-5734</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  DoD-affiliated personnel as defined in DoDI 6200.02, which includes&#xD;
             emergency-essential civilian employees and/or contractor personnel accompanying the&#xD;
             Armed Forces who are subject to the same health risk as military personnel&#xD;
&#xD;
          -  Have a laboratory-confirmed COVID-19 diagnosis with moderate to severe disease&#xD;
             presentation as determined by the principal investigator&#xD;
&#xD;
          -  Patient or legally authorized representative (LAR) provides written informed consent,&#xD;
             except as noted in 21 CFR 50.23&#xD;
&#xD;
          -  Understands and agrees to comply with planned study procedures&#xD;
&#xD;
          -  Available for clinical follow-up for duration of the treatment and follow-up period&#xD;
&#xD;
          -  Woman of childbearing potential must&#xD;
&#xD;
               -  Have a negative pregnancy test within 24 hours before starting treatment&#xD;
&#xD;
               -  Agree not to become pregnant during treatment and for 1 months after receiving&#xD;
                  remdesivir (Treatment will be a maximum of 10 doses given over a 10-day interval)&#xD;
&#xD;
               -  Use at least 2 reliable forms of effective contraception, including 1 barrier&#xD;
                  method, during treatment and for 1 month after the treatment period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ALT/AST ≥ 5 times the upper limit of normal&#xD;
&#xD;
          -  Stage 4 severe kidney disease or requiring dialysis (i.e. eGFR &lt;30)&#xD;
&#xD;
          -  Anticipated transfer to another hospital that is not a study site within 72 hours&#xD;
&#xD;
          -  Allergy to any components of the study medication [GS-5734, sulfobutylether&#xD;
             β-cyclodextrin sodium (SBECD) and hydrochloric acid and/or sodium hydroxide]&#xD;
&#xD;
          -  Concomitant antiviral therapy (lopinavir/ritonavir [Kaletra])&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Naval Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Hospital Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32214-5005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benning Martin Army Community Hospital</name>
      <address>
        <city>Fort Benning</city>
        <state>Georgia</state>
        <zip>31905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisenhower Army Medical Center</name>
      <address>
        <city>Fort Gordon</city>
        <state>Georgia</state>
        <zip>30905-5741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tripler Army Medical Center</name>
      <address>
        <city>Tripler AMC</city>
        <state>Hawaii</state>
        <zip>96859-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blanchfield Army Community Hospital</name>
      <address>
        <city>Fort Campbell North</city>
        <state>Kentucky</state>
        <zip>42223-5318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Camp Lejeune</name>
      <address>
        <city>Camp Lejeune</city>
        <state>North Carolina</state>
        <zip>28547-2538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Womack Army Medical Center</name>
      <address>
        <city>Fort Bragg</city>
        <state>North Carolina</state>
        <zip>28310-7324</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Army Medical Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79920-5001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carl R. Darnall Army Medical Center</name>
      <address>
        <city>Fort Hood</city>
        <state>Texas</state>
        <zip>76544-5095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234-4504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708-2197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madigan Army Medical Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98431-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Craig Joint Theater Hospital</name>
      <address>
        <city>Bagrām</city>
        <zip>09354</zip>
        <country>Afghanistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NATO Role 3 Multinational Medical Unit Kandahar Air Field</name>
      <address>
        <city>Kandahar</city>
        <country>Afghanistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EMF Camp Lemonnier</name>
      <address>
        <city>Djibouti</city>
        <country>Djibouti</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landstuhl Regional Medical Center</name>
      <address>
        <city>Landstuhl</city>
        <state>APO Ae</state>
        <zip>09180</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>US Naval Hospital Guam</name>
      <address>
        <city>Agaña</city>
        <zip>96910</zip>
        <country>Guam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baghdad Diplomatic Support Center</name>
      <address>
        <city>Baghdad</city>
        <zip>09305</zip>
        <country>Iraq</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>US Naval Hospital Okinawa</name>
      <address>
        <city>Okinawa</city>
        <zip>904-0103</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>US Military Hospital Kuwait 411th Hospital Center</name>
      <address>
        <city>Kuwait</city>
        <zip>09366-9998</zip>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Afghanistan</country>
    <country>Djibouti</country>
    <country>Germany</country>
    <country>Guam</country>
    <country>Iraq</country>
    <country>Japan</country>
    <country>Kuwait</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 2, 2020</study_first_submitted>
  <study_first_submitted_qc>March 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>GS-5734</keyword>
  <keyword>Remdesivir</keyword>
  <keyword>SARS-CoV-2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 23, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT04302766/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

